26 results on '"Pissot‐Soldermann, Carole"'
Search Results
2. Data from Modulation of Activation-Loop Phosphorylation by JAK Inhibitors Is Binding Mode Dependent
3. Supplementary Figures, Methods, and References from Modulation of Activation-Loop Phosphorylation by JAK Inhibitors Is Binding Mode Dependent
4. Supplementary Data from Potent and Selective Inhibition of Polycythemia by the Quinoxaline JAK2 Inhibitor NVP-BSK805
5. Discovery of New Binders for DCAF1, an Emerging Ligase Target in the Targeted Protein Degradation Field.
6. Discovery of the Clinical Candidate MAK683: An EED-Directed, Allosteric, and Selective PRC2 Inhibitor for the Treatment of Advanced Malignancies
7. Discovery of Potent, Highly Selective, and In Vivo Efficacious, Allosteric MALT1 Inhibitors by Iterative Scaffold Morphing
8. Optimization of the In Vivo Potency of Pyrazolopyrimidine MALT1 Protease Inhibitors by Reducing Metabolism and Increasing Potency in Whole Blood
9. Stabilizing Inactive Conformations of MALT1 as an Effective Approach to Inhibit Its Protease Activity
10. N-aryl-piperidine-4-carboxamides as a novel class of potent inhibitors of MALT1 proteolytic activity
11. The T-cell fingerprint of MALT1 paracaspase revealed by selective inhibition
12. Optimization of the In VivoPotency of Pyrazolopyrimidine MALT1 Protease Inhibitors by Reducing Metabolism and Increasing Potency in Whole Blood
13. Discovery of Potent, Highly Selective, and In VivoEfficacious, Allosteric MALT1 Inhibitors by Iterative Scaffold Morphing
14. The T‐cell fingerprint of MALT1 paracaspase revealed by selective inhibition.
15. Discovery of a Dihydroisoquinolinone Derivative (NVP-CGM097): A Highly Potent and Selective MDM2 Inhibitor Undergoing Phase 1 Clinical Trials in p53wt Tumors
16. Discovery and SAR of potent, orally available 2,8-diaryl-quinoxalines as a new class of JAK2 inhibitors
17. Design of two new chemotypes for inhibiting the Janus kinase 2 by scaffold morphing
18. 2-Amino-aryl-7-aryl-benzoxazoles as potent, selective and orally available JAK2 inhibitors
19. Abstract 1797: Discovery of NVP-CGM097, a highly potent and optimized small molecule inhibitor of Mdm2 under evaluation in a Phase I clinical trial
20. Modulation of Activation-Loop Phosphorylation by JAK Inhibitors Is Binding Mode Dependent
21. Potent and Selective Inhibition of Polycythemia by the Quinoxaline JAK2 Inhibitor NVP-BSK805
22. A Short and Concise Asymmetric Synthesis of Hamigeran B (I).
23. A Short and Concise Asymmetric Synthesis of Hamigeran B
24. An Asymmetric Synthesis of Hamigeran B (VIII) via a Pd Asymmetric Allylic Alkylation for Enantiodiscrimination
25. An Asymmetric Synthesis of Hamigeran B via a Pd Asymmetric Allylic Alkylation for Enantiodiscrimination
26. A short and concise asymmetric synthesis of hamigeran B.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.